Han Ying

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

GYRE

Current role

CEO, Board Member

2023-10-30–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Gyre Therapeutics, Inc. (GYRE)	Senior Vice President, Science and Former Chief Executive Officer	$309,018	—	—	—	$35,000	$9,297	$353,315
2024	Gyre Therapeutics, Inc. (GYRE)	Chief Executive Officer	$338,614	—	—	$2,503,401	$35,000	$11,125	$2,888,140

No earnings-call appearances or filed executive changes recorded yet.